Paracrine changes in the peritoneal environment of women with endometriosis - PubMed (original) (raw)

. 1998 Sep-Oct;4(5):719-23.

doi: 10.1093/humupd/4.5.719.

Affiliations

• PMID: 10027625
• DOI: 10.1093/humupd/4.5.719

Paracrine changes in the peritoneal environment of women with endometriosis

W Küpker et al. Hum Reprod Update. 1998 Sep-Oct.

Abstract

During the past decade, macrophage-derived substances such as prostanoids, cytokines, growth factors and angiogenic factors have been detected in the peritoneal fluid of women with endometriosis. In particular, growth-promoting and angiogenic factors are considered to be substantially involved in the pathogenesis of endometriosis. In this study, vascular endothelial growth factor (VEGF), transforming growth factor beta (TGF-beta) and intercellular adhesion molecule 1 (ICAM-1), substances recently detected in the peritoneal fluid of women with endometriosis, were assessed with regard to their concentrations in different stages of endometriosis and changes of the peritoneal paracrine activity after medical treatment with a gonadotrophin releasing hormone agonist (GnRHa). Peritoneal fluid was obtained from patients with endometriosis during laparoscopy before and after a 4-month treatment with a GnRHa. VEGF, TGF-beta and ICAM-1 could be detected in all women presenting with various stages of active endometriosis. After GnRHa therapy, all patients showed significant decreases in mean concentrations of VEGF (194+/-77 pg/ml), TGF-beta (902+/-273 pg/ml) and ICAM-1 (157+/-52 ng/ml). Patients with stage III and IV endometriosis (according to the rAFS score) had much higher concentrations of VEGF and TGF-beta before treatment compared with those patients with mild endometriosis (rAFS stages I and II). The most striking decrease in concentration was for TGF-beta, from 902 pg/ml before to 273 pg/ml after therapy. These results indicate an important role for paracrine activity in the establishment and maintenance of endometriosis. Indeed, treatment with a GnRHa may reduce paracrine activity in the peritoneal cavity via hypo-oestrogenism and provide proof of successful therapy.

PubMed Disclaimer

Similar articles

• Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.
  McLaren J, Prentice A, Charnock-Jones DS, Millican SA, Müller KH, Sharkey AM, Smith SK. McLaren J, et al. J Clin Invest. 1996 Jul 15;98(2):482-9. doi: 10.1172/JCI118815. J Clin Invest. 1996. PMID: 8755660 Free PMC article.
• Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis.
  McLaren J, Prentice A, Charnock-Jones DS, Smith SK. McLaren J, et al. Hum Reprod. 1996 Jan;11(1):220-3. doi: 10.1093/oxfordjournals.humrep.a019023. Hum Reprod. 1996. PMID: 8671190
• [VEGF, TNF-alpha and IL-6 in the peritoneal fluid of women with unexplained infertility].
  Miedzybrodzki R, Jedryka M, Goluda M, Fortuna W, Szymaniec S, Gabryś M. Miedzybrodzki R, et al. Ginekol Pol. 2001 May;72(5):427-30. Ginekol Pol. 2001. PMID: 11526788 Polish.
• Endometriotic disease: the role of peritoneal fluid.
  Koninckx PR, Kennedy SH, Barlow DH. Koninckx PR, et al. Hum Reprod Update. 1998 Sep-Oct;4(5):741-51. doi: 10.1093/humupd/4.5.741. Hum Reprod Update. 1998. PMID: 10027629 Review.
• Vascular endothelial growth factor and endometriotic angiogenesis.
  McLaren J. McLaren J. Hum Reprod Update. 2000 Jan-Feb;6(1):45-55. doi: 10.1093/humupd/6.1.45. Hum Reprod Update. 2000. PMID: 10711829 Review.

Cited by

• Nobiletin alleviates endometriosis via down-regulating NF-κB activity in endometriosis mouse model.
  Wei X, Shao X. Wei X, et al. Biosci Rep. 2018 Jun 21;38(3):BSR20180470. doi: 10.1042/BSR20180470. Print 2018 Jun 29. Biosci Rep. 2018. PMID: 29871974 Free PMC article.
• A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis.
  Tamura H, Takasaki A, Nakamura Y, Numa F, Sugino N. Tamura H, et al. J Ovarian Res. 2014 Oct 21;7:100. doi: 10.1186/s13048-014-0100-8. J Ovarian Res. 2014. PMID: 25331066 Free PMC article.
• A baboon model for endometriosis: implications for fertility.
  Hastings JM, Fazleabas AT. Hastings JM, et al. Reprod Biol Endocrinol. 2006;4 Suppl 1(Suppl 1):S7. doi: 10.1186/1477-7827-4-S1-S7. Reprod Biol Endocrinol. 2006. PMID: 17118171 Free PMC article. Review.
• The peritoneum is both a source and target of TGF-β in women with endometriosis.
  Young VJ, Brown JK, Saunders PT, Duncan WC, Horne AW. Young VJ, et al. PLoS One. 2014 Sep 10;9(9):e106773. doi: 10.1371/journal.pone.0106773. eCollection 2014. PLoS One. 2014. PMID: 25207642 Free PMC article.
• TGF-βI Regulates Cell Migration through Pluripotent Transcription Factor OCT4 in Endometriosis.
  Au HK, Chang JH, Wu YC, Kuo YC, Chen YH, Lee WC, Chang TS, Lan PC, Kuo HC, Lee KL, Lee MT, Tzeng CR, Huang YH. Au HK, et al. PLoS One. 2015 Dec 16;10(12):e0145256. doi: 10.1371/journal.pone.0145256. eCollection 2015. PLoS One. 2015. PMID: 26675296 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal